Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT with Reflex to HIV-1 Drug Resistance by Next Generation Sequencing
Ordering Recommendation
Use to detect and quantify HIV-1. Use to determine HIV-1 drug resistance by DNA sequencing.
Mnemonic
Methodology
Quantitative Transcription-Mediated Amplification/Massively Parallel Sequencing
Performed
Sun-Sat
Reported
2-14 days
New York DOH Approval Status
Specimen Required
Lavender (EDTA), Pink (K2EDTA), or Plasma Preparation Tube (PPT).
Separate from cells within 24 hours of collection. Transfer 4 mL plasma to an ARUP Standard Transport Tube and freeze. (Min: 2.5 mL)
Frozen
Serum. Heparinized specimens.
After separation from cells: Ambient: Unacceptable; Refrigerated: 72 hours; Frozen: 3 months
Reference Interval
Test Number |
Components |
Reference Interval |
---|---|---|
HIV-1 Qnt by NAAT Interp | Not Detected |
Interpretive Data
Refer to report
FDA
Note
If Human Immunodeficiency Virus 1 by Quantitative NAAT result is greater than or equal to 2.70 log copies/mL, then HIV- Drug Resistance by Next Generation Sequencing will be added. Additional charges apply.
Hotline History
Hotline History
CPT Codes
87536; if reflexed add 87900; 87901; 87906
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3000868 | HIV-1 Qnt by NAAT (copies/mL) | 20447-9 |
3000869 | HIV-1 Qnt by NAAT (log copies/mL) | 29541-0 |
3000970 | HIV-1 Qnt by NAAT Interp | 25835-0 |
Aliases
- HIV genotyping for drug sensitivity testing
- HIV-1 reflex to genotyping
- HIV-1 Treatment decision
- HIV-1 viral load
- Nucleic Acid Amplification Test (NAAT)
- Viral load monitoring